Oscar Health/$OSCR
1D1W1MYTD1Y5YMAX
Capital at risk
About Oscar Health
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
- Ticker
- $OSCR
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 2,305
- Headquarters
- New York, United States
- Website
- www.hioscar.com
Oscar Health Metrics
BasicAdvanced
$10B
17.00
$1.91
2.39
-
Price and volume
Market cap
$10B
Beta
2.39
52-week high
$34.48
52-week low
$10.69
Average daily volume
5.6M
Financial strength
Current ratio
1.079
Quick ratio
1.049
Long term debt to equity
0.235
Total debt to equity
0.235
Interest coverage (TTM)
39.73%
Profitability
EBITDA (TTM)
657.964
Gross margin (TTM)
20.16%
Net profit margin (TTM)
3.60%
Operating margin (TTM)
4.11%
Effective tax rate (TTM)
6.59%
Revenue per employee (TTM)
$6,650,000
Management effectiveness
Return on assets (TTM)
4.47%
Return on equity (TTM)
34.26%
Valuation
Price to earnings (TTM)
17.002
Price to revenue (TTM)
0.605
Price to book
4.87
Price to tangible book (TTM)
4.87
Price to free cash flow (TTM)
2.117
Free cash flow yield (TTM)
47.25%
Free cash flow per share (TTM)
15.326
Growth
Revenue change (TTM)
42.82%
Earnings per share change (TTM)
-375.10%
3-year revenue growth (CAGR)
45.41%
3-year earnings per share growth (CAGR)
-4.64%
What the Analysts think about Oscar Health
Analyst ratings (Buy, Hold, Sell) for Oscar Health stock.
Analyst projections of the future price of Oscar Health stock.
Bulls say / Bears say
Oscar Health posted net income of $361.8 million in Q2 2026, swinging from a $228.4 million loss a year earlier, and raised its full-year earnings-from-operations guidance by $250 million to a range of $500 million–$700 million. (Yahoo Finance)
Total revenue grew 70% year-over-year to approximately $4.9 billion in Q2 2026, driven by a 46% increase in effectuated membership and rate adjustments. (Yahoo Finance)
Oscar’s medical loss ratio improved to 79.2% in Q2 2026 from 91.1% in Q2 2025, reflecting disciplined pricing and favorable prior-period reserve development. (SEC)
MLR improvement in Q2 was partially driven by $164 million of favorable prior-period reserve development, which may not recur and could lead to a deterioration in loss ratios if reserves normalize. (Reuters)
Oscar has priced for a 20%–30% marketplace shrinkage due to the expiration of enhanced premium subsidies, underscoring the risk of significant membership declines as federal support lapses. (Investing.com)
Risk adjustment transfer payables represented approximately 24% of direct policy premium revenue in Q1 2026, up 13% year-over-year, exposing margins to volatility in program estimates and accruals. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2026.
Oscar Health Financial Performance
Revenues and expenses
Oscar Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Oscar Health News
AllArticlesVideos
Funds containing Oscar Health
AllEURGBPUSD
Fund name | Fund size | $OSCR weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.59% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.27% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.11% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.11% |
iShares MSCI World Small Cap$WSML | $9B | 0.07% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.